Show simple item record

dc.contributor.authorAmmons, Mary Cloud B.
dc.contributor.authorWard, L. S.
dc.contributor.authorJames, Garth A.
dc.date.accessioned2017-02-06T16:57:15Z
dc.date.available2017-02-06T16:57:15Z
dc.date.issued2011-04
dc.identifier.citationAmmons MC, Ward LS, James GA, "Anti-biofilm efficacy of a lactoferrin/xylitol wound hydrogel used in combination with silver wound dressings," International Wound Journal, April 2011 8(3):268-273.en_US
dc.identifier.issn1742-4801
dc.identifier.urihttps://scholarworks.montana.edu/xmlui/handle/1/12559
dc.description.abstractWith an epidemic increase in obesity combined with an ageing population, chronic wounds such as diabetic foot ulcers, pressure ulcers and venous leg ulcers are an increasing clinical concern. Recent studies have shown that bacterial biofilms are a major contributor to wound bioburden and interfere with the normal wound healing process; therefore, rational design of wound therapies should include analysis of anti-biofilm characteristics. Studies using the combined treatment of bacterial biofilms with the innate immune molecule lactoferrin and the rare sugar-alcohol xylitol have demonstrated an antimicrobial capacity against a clinical wound isolate.Studies presented here used a colony-drip-flow reactor biofilm model to assess the anti-biofilm efficacy of a lactoferrin/xylitol hydrogel used in combination with commercially available silver-based wound dressings. Log reductions in biofilm viability are compared with a commercially available wound hydrogel used in combination with the silver-based wound dressings. For both a single species biofilm and a dual species biofilm, the lactoferrin/xylitol hydrogel in combination with the silver wound dressing Acticoatâ„¢ had a statistically significant reduction in biofilm viability relative to the commercially available wound hydrogel. This study also demonstrated a statistical interaction between the lactoferrin/xylitol hydrogel and the silver wound dressing.en_US
dc.titleAnti-biofilm efficacy of a lactoferrin/xylitol wound hydrogel used in combination with silver wound dressingsen_US
dc.typeArticleen_US
mus.citation.extentfirstpage268en_US
mus.citation.extentlastpage273en_US
mus.citation.issue3en_US
mus.citation.journaltitleInternational Wound Journalen_US
mus.citation.volume8en_US
mus.identifier.categoryChemical & Material Sciencesen_US
mus.identifier.categoryEngineering & Computer Scienceen_US
mus.identifier.categoryHealth & Medical Sciencesen_US
mus.identifier.categoryLife Sciences & Earth Sciencesen_US
mus.identifier.doi10.1111/j.1742-481x.2011.00781.xen_US
mus.relation.collegeCollege of Agricultureen_US
mus.relation.collegeCollege of Engineeringen_US
mus.relation.collegeCollege of Letters & Scienceen_US
mus.relation.departmentCenter for Biofilm Engineering.en_US
mus.relation.departmentChemical & Biological Engineering.en_US
mus.relation.departmentChemical Engineering.en_US
mus.relation.departmentChemistry & Biochemistry.en_US
mus.relation.departmentHealth & Human Development.en_US
mus.relation.departmentMicrobiology & Immunology.en_US
mus.relation.universityMontana State University - Bozemanen_US
mus.relation.researchgroupCenter for Biofilm Engineering.en_US
mus.data.thumbpage3en_US
mus.contributor.orcidAmmons, Mary Cloud B.|0000-0002-9717-0844en_US


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record


MSU uses DSpace software, copyright © 2002-2017  Duraspace. For library collections that are not accessible, we are committed to providing reasonable accommodations and timely access to users with disabilities. For assistance, please submit an accessibility request for library material.